Syncytin-A inhibitors are a class of compounds designed to specifically target and inhibit the activity of Syncytin-A, a membrane protein involved in cell-cell fusion processes. Syncytin-A is derived from an endogenous retroviral envelope protein and plays a critical role in the fusion of trophoblast cells to form the syncytiotrophoblast layer in the placenta. This fusion is essential for the formation of a multinucleated structure that facilitates nutrient exchange between the mother and the developing embryo. Syncytin-A mediates membrane fusion through its interaction with specific receptors on adjacent cells, initiating the process that leads to the merging of the cell membranes. Inhibitors of Syncytin-A work by blocking these interactions, thereby preventing the fusion of cells and disrupting the formation of syncytial layers.
The chemical structure of Syncytin-A inhibitors varies depending on their mechanism of action. Some inhibitors may directly bind to the receptor-binding domains of Syncytin-A, preventing it from interacting with cellular receptors necessary for initiating fusion. Others might affect the fusogenic domain of Syncytin-A, altering its ability to mediate the membrane merging process. These inhibitors can interfere with the structural rearrangements required for membrane fusion, ultimately blocking the syncytialization process. Studying Syncytin-A inhibitors provides valuable insights into the molecular mechanisms underlying cell-cell fusion events, particularly in developmental biology and placental function. Additionally, understanding the inhibition of Syncytin-A offers a broader perspective on how endogenous retroviral proteins have been co-opted for physiological processes such as tissue formation and cellular differentiation. This knowledge contributes to the broader understanding of cell fusion mechanisms and their importance in multicellular organism development.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin may inhibit the expression of syncytin A by interfering with transcription factors and downregulating gene expression. Its anti-inflammatory properties might impact signaling pathways involved in the expression of this protein. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol's ability to modulate transcription factors and inhibit gene expression could lead to the downregulation of syncytin A. Its antioxidant properties may also play a role in reducing the expression of this protein. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG can potentially inhibit the expression of syncytin A by modulating various signaling pathways involved in gene expression regulation. Its antioxidant properties may also contribute to reducing the expression of this protein. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin's modulation of signaling pathways and inhibition of transcription factors might result in the downregulation of syncytin A expression. Additionally, its antioxidant properties could play a role in reducing the expression of this protein. | ||||||
Berberine | 2086-83-1 | sc-507337 | 250 mg | $92.00 | 1 | |
Berberine's interference with transcription factors and modulation of gene expression may lead to the inhibition of syncytin A expression. Its anti-inflammatory effects might also impact relevant signaling pathways involved in the expression of this protein. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein's ability to modulate transcription factors and signaling pathways involved in gene expression could result in the downregulation of syncytin A. Additionally, its anti-inflammatory properties may influence the expression of this protein. | ||||||
Luteolin | 491-70-3 | sc-203119 sc-203119A sc-203119B sc-203119C sc-203119D | 5 mg 50 mg 500 mg 5 g 500 g | $27.00 $51.00 $101.00 $153.00 $1925.00 | 40 | |
Luteolin's modulation of gene expression through various signaling pathways may inhibit the expression of syncytin A. Its anti-inflammatory effects might also contribute to reducing the expression of this protein by impacting relevant pathways. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Sulforaphane may inhibit the expression of syncytin A by modulating gene expression through epigenetic mechanisms and inhibiting transcription factors. Its anti-inflammatory properties could also impact signaling pathways involved in the expression of this protein. | ||||||
Emodin | 518-82-1 | sc-202601 sc-202601A sc-202601B | 50 mg 250 mg 15 g | $105.00 $214.00 $6255.00 | 2 | |
Emodin's interference with transcription factors and modulation of signaling pathways may lead to the inhibition of syncytin A expression. Additionally, its anti-inflammatory effects could influence relevant pathways involved in the expression of this protein. | ||||||
Naringenin | 480-41-1 | sc-219338 | 25 g | $245.00 | 11 | |
Naringenin's modulation of signaling pathways and inhibition of transcription factors might result in the downregulation of syncytin A expression. Additionally, its antioxidant properties could contribute to reducing the expression of this protein. | ||||||